Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors

P. F. Kador, Y. Akagi, Y. Takahashi, H. Ikebe, M. Wyman and J. H. Kinoshita
National Eye Institute, National Institutes of Health, Bethesda, Md 20892.

Vascular changes associated with early diabetic retinopathy that include the selective degeneration of pericytes, the formation of microaneurysms and acellular capillaries, and vessel dilation have been experimentally investigated in age- and sex-matched beagle dogs fed a 30% galactose diet and treated with or without the aldose reductase inhibitors sorbinil and/or M79175. Eyes from dogs in each group were periodically enucleated during a 36-month period and their retinal capillaries were examined as trypsin-digested flat preparations. These studies reveal that the destruction of retinal pericytes to form pericyte ghosts is the earliest observable retinal vessel change occurring after 19 to 21 months of galactose feeding. By 24 months, both an irregular distribution of endothelial cell nuclei near pericyte ghosts and the presence of acellular capillaries containing neither endothelial cells nor pericytes can be observed. This was followed by the histologic appearance of microaneurysms after 27 months and the funduscopic appearance of intraretinal hemorrhages after 33 months. Varicose enlargements of capillaries were also observed in the trypsin-digested preparations from dogs fed galactose for 33 to 36 months. All of these changes are linked to the initial aldose reductase-associated destruction of pericytes. The onset and progression of these retinal changes were retarded in a dose-dependent manner with aldose reductase inhibitors.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of the Polyol Pathway in High Glucose-Induced Apoptosis of Retinal Pericytes and Proliferation of Endothelial Cells
Takamura et al.
IOVS 2008;49:3216-3223.
ABSTRACT | FULL TEXT  

Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Dagher et al.
Diabetes 2004;53:2404-2411.
ABSTRACT | FULL TEXT  

Effect of Dicarbonyl Modification of Fibronectin on Retinal Capillary Pericytes
Liu et al.
IOVS 2004;45:1983-1995.
ABSTRACT | FULL TEXT  

Potential Contributory Role of H-Ras, a Small G-Protein, in the Development of Retinopathy in Diabetic Rats
Kowluru et al.
Diabetes 2004;53:775-783.
ABSTRACT | FULL TEXT  

Effects of Aldose Reductase Inhibitors and Galactose Withdrawal on Fluorescein Angiographic Lesions in Galactose-Fed Dogs
Cusick et al.
Arch Ophthalmol 2003;121:1745-1751.
ABSTRACT | FULL TEXT  

Correlation between erythrocyte aldose reductase level and human diabetic retinopathy
Oishi et al.
Br. J. Ophthalmol. 2002;86:1363-1366.
ABSTRACT | FULL TEXT  

Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz and King
JAMA 2002;288:2579-2588.
ABSTRACT | FULL TEXT  

Termination of Experimental Galactosemia in Rats, and Progression of Retinal Metabolic Abnormalities
Kowluru and Koppolu
IOVS 2002;43:3287-3291.
ABSTRACT | FULL TEXT  

Effect of Galactose Diet Removal on the Progression of Retinal Vessel Changes in Galactose-Fed Dogs
Kador et al.
IOVS 2002;43:1916-1921.
ABSTRACT | FULL TEXT  

Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia: VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy
Kowluru et al.
Diabetes 2001;50:1938-1942.
ABSTRACT | FULL TEXT  

Treatment of Diabetic Retinopathy
Ferris et al.
NEJM 1999;341:667-678.
FULL TEXT  

Retinal Vessel Changes in Galactose-Fed Dogs
Kobayashi et al.
Arch Ophthalmol 1998;116:785-789.
ABSTRACT | FULL TEXT